{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:30:16Z","timestamp":1786501816979,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156559","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:33:47Z","timestamp":1779492827000},"page":"156559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanism of METTL3 promoting rituximab resistance via \u03b2-catenin\/MYC axis in double-expressor diffuse large B cell lymphoma"],"prefix":"10.1016","volume":"286","author":[{"given":"Yanming","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2026.156559_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/hon.3202","article-title":"Diffuse large B-cell lymphoma","volume":"42","author":"Barraclough","year":"2024","journal-title":"Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.prp.2026.156559_bib2","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1182\/bloodadvances.2024013699","article-title":"Increased CCL2\/CCR2 axis promotes tumor progression by increasing M2 macrophages in MYC\/BCL2 double-expressor DLBCL","volume":"8","author":"Kim","year":"2024","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.prp.2026.156559_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf085","article-title":"Recent advancements in double-expressor lymphoma: novel therapeutic approaches and prospects","volume":"30","author":"Zhuo","year":"2025","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib4","first-page":"51","article-title":"Current frontline treatment of diffuse large B-cell lymphoma","volume":"36","author":"Spinner","year":"2022","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.prp.2026.156559_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7173","article-title":"Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy","volume":"13","author":"Sineshaw","year":"2024","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.prp.2026.156559_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CM9.0000000000001294","article-title":"R-CHOP resistance in diffuse large B-cell lymphoma: biological and molecular mechanisms","volume":"134","author":"Wang","year":"2020","journal-title":"Chin. Med J."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11658-023-00445-w","article-title":"KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway","volume":"28","author":"Chen","year":"2023","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.prp.2026.156559_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jare.2023.10.010","article-title":"Targeting YTHDF2 inhibits tumorigenesis of diffuse large B-cell lymphoma through ACER2-mediated ceramide catabolism","volume":"63","author":"Chen","year":"2024","journal-title":"J. Adv. Res"},{"issue":"10","key":"10.1016\/j.prp.2026.156559_bib9","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1093\/nar\/gky156","article-title":"SUMOylation of the m6A-RNA methyltransferase METTL3 modulates its function","volume":"46","author":"Du","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41420-023-01698-2","article-title":"METTL3-mediated m6A methylation of C1qA regulates the Rituximab resistance of diffuse large B-cell lymphoma cells","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.prp.2026.156559_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3389\/fgene.2020.00955","article-title":"The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF","volume":"11","author":"Cheng","year":"2020","journal-title":"Front Genet"},{"issue":"17","key":"10.1016\/j.prp.2026.156559_bib12","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1093\/cvr\/cvad137","article-title":"Genetic inactivation of beta-catenin is salubrious, whereas its activation is deleterious in desmoplakin cardiomyopathy","volume":"119","author":"Olcum","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.prp.2026.156559_bib13","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429308361240823061634","article-title":"Recent advances in the glycolytic processes linked to tumor metastasis","volume":"17","author":"Qiong","year":"2024","journal-title":"Curr. Mol. Pharm."},{"issue":"5","key":"10.1016\/j.prp.2026.156559_bib14","first-page":"1423","article-title":"Mechanism underlying the inhibitory effect of MiR-532-3p on the cells proliferation of diffuse large B-Cell lymphoma","volume":"30","author":"Zhang","year":"2022","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.prp.2026.156559_bib15","article-title":"E7386 is not a specific CBP\/beta-Catenin Antagonist","volume":"17","author":"Higuchi","year":"2024","journal-title":"Curr. Mol. Pharm."},{"issue":"4","key":"10.1016\/j.prp.2026.156559_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ymthe.2022.01.019","article-title":"RNA m(6)A methylation regulates dissemination of cancer cells by modulating expression and membrane localization of beta-catenin","volume":"30","author":"Li","year":"2022","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib17","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8840","article-title":"Huaier promotes sensitivity of colorectal cancer to oxaliplatin by inhibiting METTL3 to regulate the Wnt\/beta\u2011catenin signaling pathway","volume":"53","author":"Huo","year":"2025","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.prp.2026.156559_bib18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.7150\/ijbs.96233","article-title":"m(6)A RNA methylation drives kidney fibrosis by upregulating beta-catenin signaling","volume":"20","author":"Long","year":"2024","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156559_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102154","article-title":"MYC as a target for cancer treatment","volume":"94","author":"Duffy","year":"2021","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.prp.2026.156559_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22095022","article-title":"Trichodermin Induces G0\/G1 Cell Cycle Arrest by Inhibiting c-Myc in Ovarian Cancer Cells and Tumor Xenograft-Bearing Mice","volume":"22","author":"Gao","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156559_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100909","article-title":"The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity","volume":"66","author":"Di","year":"2023","journal-title":"Drug Resist Updat"},{"issue":"14","key":"10.1016\/j.prp.2026.156559_bib22","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1158\/1078-0432.CCR-24-0256","article-title":"MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance","volume":"30","author":"Davis","year":"2024","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12967-022-03456-x","article-title":"Tumor-suppressive MEG3 induces microRNA-493-5p expression to reduce arabinocytosine chemoresistance of acute myeloid leukemia cells by downregulating the METTL3\/MYC axis","volume":"20","author":"Wang","year":"2022","journal-title":"J. Transl. Med"},{"issue":"8","key":"10.1016\/j.prp.2026.156559_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41419-023-06067-6","article-title":"N(6)-methyladenosine modification of REG1alpha facilitates colorectal cancer progression via beta-catenin\/MYC\/LDHA axis mediated glycolytic reprogramming","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib25","first-page":"54","article-title":"Melatonin inhibits ESCC tumor growth by mitigating the HDAC7\/beta-catenin\/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability","volume":"9","author":"Ma","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct. Target Ther."},{"issue":"23","key":"10.1016\/j.prp.2026.156559_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312961","article-title":"Primaquine Inhibits the Endosomal Trafficking and Nuclear Localization of EGFR and Induces the Apoptosis of Breast Cancer Cells by Nuclear EGFR\/Stat3-Mediated c-Myc Downregulation","volume":"22","author":"Kim","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41375-021-01347-6","article-title":"Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma","volume":"36","author":"Rossi","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.prp.2026.156559_bib29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cell.2017.03.031","article-title":"Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation","volume":"169","author":"Slobodin","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-026-03855-4","article-title":"METTL3-mediated m(6)A modification regulates CDKN1A to attenuate chronic sleep deprivation-induced cognitive impairment and neuronal apoptosis in rats","volume":"16","author":"Xing","year":"2026","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib31","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-026-02484-9","article-title":"METTL3-Mediated m6A Regulation of CircINTS4\/miR-146b-3p Axis in Rheumatoid Arthritis","volume":"49","author":"Li","year":"2026","journal-title":"Inflammation"},{"key":"10.1016\/j.prp.2026.156559_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216122","article-title":"METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-021-02227-8","article-title":"METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"362","key":"10.1016\/j.prp.2026.156559_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005654","article-title":"FOXP1 potentiates Wnt\/beta-catenin signaling in diffuse large B cell lymphoma","volume":"8","author":"Walker","year":"2015","journal-title":"Sci. Signal"},{"key":"10.1016\/j.prp.2026.156559_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102443","article-title":"Treatment strategies for patients with diffuse large B-cell lymphoma","volume":"110","author":"Poletto","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.prp.2026.156559_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110831","article-title":"TCFL5 knockdown sensitizes DLBCL to doxorubicin treatment via regulation of GPX4","volume":"110","author":"Lu","year":"2023","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.prp.2026.156559_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123553","article-title":"Molecular genetics of relapsed diffuse large B-Cell lymphoma: insight into mechanisms of therapy resistance","volume":"12","author":"Berendsen","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib38","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1038\/s41598-023-35777-2","article-title":"NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc","volume":"13","author":"Meng","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2026.156559_bib39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.biopha.2018.07.171","article-title":"CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating beta-catenin","volume":"107","author":"Ruiduo","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib40","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1038\/s41467-019-11447-8","article-title":"LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib41","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-020-01808-3","article-title":"Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b\/beta-catenin\/c-Myc signaling and reprogramming glycolysis","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.prp.2026.156559_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1042\/EBC20220016","article-title":"WNT signaling and cancer stemness","volume":"66","author":"Katoh","year":"2022","journal-title":"Essays Biochem"},{"issue":"5","key":"10.1016\/j.prp.2026.156559_bib43","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.7150\/ijbs.104598","article-title":"TMEM105 modulates disulfidptosis and tumor growth in pancreatic cancer via the beta-catenin-c-MYC-GLUT1 axis","volume":"21","author":"Yin","year":"2025","journal-title":"Int J. Biol. Sci."},{"issue":"13","key":"10.1016\/j.prp.2026.156559_bib44","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1182\/bloodadvances.2020001696","article-title":"Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma","volume":"4","author":"Rushton","year":"2020","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.prp.2026.156559_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3960\/jslrt.56.89","article-title":"Genetic and Epigenetic Modulation of CD20 Expression in B-Cell Malignancies: Molecular Mechanisms and Significance to Rituximab Resistance","volume":"56","author":"Tomita","year":"2016","journal-title":"J. Clin. Exp. Hematop"},{"issue":"9","key":"10.1016\/j.prp.2026.156559_bib46","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1002\/1878-0261.12753","article-title":"Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma","volume":"14","author":"Thomsen","year":"2020","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156559_bib47","article-title":"ITK overexpression enhances T cell cytotoxicity against DLBCL through the TCR-Ca(2+)-Calcineurin-NFAT-IFN-gamma pathway","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.prp.2026.156559_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ph18070978","article-title":"Beyond the Limit: MYC Mediates Tumor Immune Escape","volume":"18","author":"Hong","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156559_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/cas.70139","article-title":"BCL-2 Inhibitor Regulates Number, Function, and Antitumor Immunity of T Cells by Influencing Glycolysis in AML","author":"Peng","year":"2025","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.prp.2026.156559_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.168013","article-title":"Glioma cells produce soluble PD-L1 via the Wnt\/beta-catenin signaling pathway to suppress CD8+ T cell activity","volume":"1871","author":"Zhou","year":"2025","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.prp.2026.156559_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2026.173231","article-title":"The self-assembling amphibian-derived peptide (RADA)4-FZ1 pioneers a novel therapeutic platform for diabetic skin wound management","volume":"530","author":"Fu","year":"2026","journal-title":"Chem. Eng. J."},{"issue":"5","key":"10.1016\/j.prp.2026.156559_bib52","first-page":"1187","article-title":"Ultra-short cyclic peptide Cy (RL-QN15) acts as a TLR4 antagonist to expedite oral ulcer healing","volume":"46","author":"Ru","year":"2025","journal-title":"Zool. Res"},{"issue":"18","key":"10.1016\/j.prp.2026.156559_bib53","doi-asserted-by":"crossref","first-page":"19503","DOI":"10.1021\/acs.jmedchem.5c01734","article-title":"Cyclic Heptapeptide FZ1 Acts as an Integrin alphavbeta3 Agonist to Facilitate Diabetic Skin Wound Healing by Enhancing Angiogenesis","volume":"68","author":"Wang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.prp.2026.156559_bib54","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.24272\/j.issn.2095-8137.2024.134","article-title":"Peptide Cy (RL-QN15) accelerates hair regeneration in diabetic mice by binding to the Frizzled-7 receptor","volume":"45","author":"Wu","year":"2024","journal-title":"Zool. Res"},{"key":"10.1016\/j.prp.2026.156559_bib55","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429263063231204095516","article-title":"Anticancer properties of baicalin against breast cancer and other gynecological cancers: therapeutic opportunities based on underlying mechanisms","volume":"17","author":"Pourhanifeh","year":"2024","journal-title":"Curr. Mol. Pharm."},{"key":"10.1016\/j.prp.2026.156559_bib56","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429305367240725112731","article-title":"Positive regulation of osteoblast proliferation and differentiation in MC3T3- E1 Cells by 7,3\u2032,4\u2032-trimethoxyflavone","volume":"17","author":"Fayyaz","year":"2024","journal-title":"Curr. Mol. Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:24:07Z","timestamp":1786501447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":56,"alternative-id":["S0344033826002128"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156559","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of METTL3 promoting rituximab resistance via \u03b2-catenin\/MYC axis in double-expressor diffuse large B cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156559"}}